ASCO Report 2014: The evolution of our molecular understanding of Colorectal Cancer
What we are doing now, what the future Holds, and how Tumour profiling is just the beginning by Dr Paul Ross, Guy’s & St Thomas’ Hospitals, London. At… read more.
What we are doing now, what the future Holds, and how Tumour profiling is just the beginning by Dr Paul Ross, Guy’s & St Thomas’ Hospitals, London. At… read more.
by Bruce Sylvester – Ibrutinib has significantly outperformed ofatumumab as a second-line therapy for chronic lymphocytic leukemia (CLL), according to a Phase 3 study published on May 31,… read more.
by Bruce Sylvester: Rapamycin appears to shrink one type of pancreatic cancer tumor and prevents it from spreading, researchers reported on August 3, 2014 in the journal Gut.
by Bruce Sylvester: In spite of preclinical signs of preventing tumor progression and improving survival, everolimus does not improve overall survival in patients with advanced liver cancer when… read more.
Lugano, Switzerland, 25 July 2014. The European Society for Medical Oncology (ESMO), the leading pan-European association representing medical oncology professionals, has expressed concern that the proposed EU General… read more.
by Esther Drain – Skin cancer is now the commonest cancer in the UK and the incidence is rising, mainly due to people taking more holidays in sunny… read more.
by Bruce Sylvester – 3D Mammography detects a significantly higher rate of invasive cancers and reduces the rate of unnecessary recalls, researchers reported on June 25, 2014 in… read more.
by Bruce Sylvester – Adding goserelin to standard chemotherapy significantly reduces the risk of early menopause in breast cancer patients, researchers reported in May of 2014 at the… read more.
Pan-European Survey reveals low levels of asthma control in Ireland. Irish respondents are experiencing asthma symptoms nearly 3 days a week. 48% of Irish people with asthma are… read more.
by Bruce Sylvester – Colon cancer patients diagnosed before age 50 have more advanced stages of colon cancer at diagnosis but have better survival at all stages of… read more.
Significant survival benefit observed in women with HER2 negative breast cancer – ASCO Press Release.
Pivotal phase III data for lenvatinib to be presented in a Head and Neck Cancer oral session at American Society of Clinical Oncology congress (ASCO) – Press Release.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.